SEARCH

SEARCH BY CITATION

References

  • 1
    Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: A global perspective. Vaccine 1999; 17: 17303.
  • 2
    Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin. Microbiol. Rev. 1999; 12: 35166.
  • 3
    Seeger C, Mason WS. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000; 64: 5168.
  • 4
    Perelson AS, Essunger P, Ho DD. Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 1997; 11: S1724.
  • 5
    Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc. Natl Acad. Sci. USA 1996; 93: 4398402.
  • 6
    Zeuzem S, De Man RAPH, Roth WK, Schalm SW, Schmidt JM. Dynamics of hepatitis B virus infection in vivo. J. Hepatol. 1997, 1997; 27: 4316.
  • 7
    Drouet J, Courouce-Pauty AM, Thevenoux AM et al. Kinetics of HBs antigen in man. Biomedicine 1975; 22: 15866.
  • 8
    Tencza MG, Newbold JE. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: Drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles. J. Med. Virol. 1997; 51: 616.
  • 9
    Zeuzem S, Schmidt JM, Lee JH, Von Wagner M, Teuber G, Roth WK. Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover. Hepatology 1998; 28: 24552.
  • 10
    Mellors JW, Bazmi HZ, Schinazi RF et al. Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates. Antimicrob. Agents Chemother. 1995; 39: 108792.
  • 11
    Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 116770.
  • 12
    Ho DD. Viral counts count in HIV infection. Science 1996; 272: 11245.
  • 13
    Herz AV, Bonhoeffer S, Anderson RM, May RM, Nowak MA. Viral dynamics in vivo: Limitations on estimates of intracellular delay and virus decay. Proc. Natl Acad. Sci. USA 1996; 93: 724751.
  • 14
    Cornelissen M, Van Den Burg R, Zorgdrager F, Lukashov V, Goudsmit J. Pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. J. Virol. 1997; 71: 634858.
  • 15
    Najera I, Holguin A, Quinones-Mateu ME et al. Pol gene quasispecies of human immunodeficiency virus: Mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 1995; 69: 2331.
  • 16
    Brown JL, Carman WF, Thomas HC. The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology 1992; 15: 1448.
  • 17
    Miller RH, Kaneko S, Chung CT, Girones R, Purcell RH. Compact organization of the hepatitis B virus genome. Hepatology 1989; 9: 3227.
  • 18
    Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology 1989; 170: 5957.
  • 19
    Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 15826.
  • 20
    Coffin JM. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 1995; 267: 4839.
  • 21
    Lewin S, Ribeiro RM, Walter T et al. Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed. Hepatology 2001; 34: 1012120.
  • 22
    Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 8259.
  • 23
    Civitico GM, Locarnini SA. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary duck hepatocyte cultures. Virology 1994; 203: 819.
  • 24
    Fields BN, Jaenisch R, Fox CF. Animal Virus Genetics. New York: Academic Press, 1980.
  • 25
    Okamoto H, Tsuda F, Sakugawa H et al. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J. Gen. Virol. 1988; 69: 257583.
  • 26
    Bichko V, Pushko P, Dreilina D, Pumpen P, Gren E. Subtype ayw variant of hepatitis B virus: DNA primary structure analysis. FEBS Lett. 1985; 185: 20812.
  • 27
    Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489503.
  • 28
    Stuyver L, De Gendt S, Van Geyt C et al. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J. Gen. Virol. 2000; 81 Part 1: 6774.
  • 29
    Norder H, Hammas B, Lee SD et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J. Gen. Virol. 1993; 74: 13418.
  • 30
    Blitz L, Pujol FH, Swenson PD et al. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J. Clin. Microbiol. 1998; 36: 64851.
  • 31
    Black FL. Infectious diseases in primitive societies. Science 1975; 187: 51518.
  • 32
    Karlen A. Man and Microbes. Disease and Plagues in History and Modern Times. New York: GP Putnam & Sons, 1995.
  • 33
    Dobson A, Carper E. Infectious diseases and human population history. Bioscience 1996; 46: 11526.
  • 34
    Macdonald D, Holmes E, Lewis C, Simmonds P. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): Phylogenetic relationships with human and other primate genotypes. J. Virol. 2000; 74: 42537.
  • 35
    Warren KS, Heeney JL, Swan RA, Heriyanto Verschoor EJ. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus). J. Virol. 1999; 73: 78605.
  • 36
    Gao F, Bailes E, Robertson DL et al. Origin of HIV-1 in the chimpanzee Pan trolodytes troglodytes. Nature 1999; 397: 43641.
  • 37
    Feng G, Yue L, White A et al. Human infection by genetically diverse SIVsm-related HIV-2 in West Africa. Nature 1992; 358: 4959.
  • 38
    Rodriguez-Frias F, Buti M, Jardi R et al. Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995; 22: 16417.
  • 39
    Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc. Natl Acad. Sci. USA 1994; 91: 407781.
  • 40
    Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region. J. Virol. 1993; 67: 540210.
  • 41
    Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus: Large-scale analysis using a new genotyping method. J. Infect. Dis. 1997; 175: 128593.
  • 42
    Laskus T, Rakela J, Nowicki MJ, Persing DH. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995; 109: 161823.
  • 43
    Laskus T, Rakela J, Persing DH. Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon. Dig. Dis. Sci. 1995; 40: 17.
  • 44
    Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J. Hepatol. 2000; 33: 9981002.
  • 45
    Orito E, Mizokami M, Sakugawa H et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001; 33: 21823.
  • 46
    Hadziyannis SJ, Papatheodoridis GV, Dimou E, Laras A, Papaioannou C. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2000; 32: 84751.
  • 47
    Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J. Viral Hepatol. 1999; 6: 299304.
  • 48
    Orito E, Ichida T, Sakugawa H et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001; 34: 5904.
  • 49
    Kao J, Chen P, Lai M. Hepatitis B genotype correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000; 2118: 5549.
  • 50
    Erhardt A, Reineke U, Blondin D et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 2000; 31: 71625.